Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124842212 | 12484221 | 2 | F | 201605 | 20160617 | 20160621 | 20160811 | PER | US-ASTRAZENECA-2016SE56025 | ASTRAZENECA | 27212.00 | DY | M | Y | 72.10000 | KG | 20160811 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124842212 | 12484221 | 1 | SS | TENORETIC | ATENOLOLCHLORTHALIDONE | 1 | Oral | DAILY | 0 | TABLET | |||||||||
| 124842212 | 12484221 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | U | U | 0 | 50 | MG | QD | |||||||
| 124842212 | 12484221 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | U | U | 0 | 10 | MG | TABLET | QD | |||||
| 124842212 | 12484221 | 4 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20.0MG AS REQUIRED | 19810 | 20 | MG | ||||||||
| 124842212 | 12484221 | 5 | SS | BRILINTA | TICAGRELOR | 1 | Oral | HC0034 | 0 | 90 | MG | TABLET | BID | ||||||
| 124842212 | 12484221 | 6 | SS | BRILINTA | TICAGRELOR | 1 | Oral | HC0034 | 0 | 90 | MG | TABLET | BID | ||||||
| 124842212 | 12484221 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 85 | MG | QD | ||||||||
| 124842212 | 12484221 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 124842212 | 12484221 | 9 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | 20 | MEQ | QD | ||||||||
| 124842212 | 12484221 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124842212 | 12484221 | 1 | Hypertension |
| 124842212 | 12484221 | 2 | Hypertension |
| 124842212 | 12484221 | 3 | Hypertension |
| 124842212 | 12484221 | 4 | Gastrooesophageal reflux disease |
| 124842212 | 12484221 | 5 | Stent placement |
| 124842212 | 12484221 | 6 | Acute coronary syndrome |
| 124842212 | 12484221 | 7 | Cardiac disorder |
| 124842212 | 12484221 | 8 | Cardiac disorder |
| 124842212 | 12484221 | 9 | Muscle spasms |
| 124842212 | 12484221 | 10 | Blood cholesterol abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124842212 | 12484221 | Abdominal pain upper | |
| 124842212 | 12484221 | Drug dose omission | |
| 124842212 | 12484221 | Gallbladder disorder | |
| 124842212 | 12484221 | Rash | |
| 124842212 | 12484221 | Urticaria | |
| 124842212 | 12484221 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124842212 | 12484221 | 3 | 20160608 | 0 | ||
| 124842212 | 12484221 | 5 | 20160421 | 0 | ||
| 124842212 | 12484221 | 6 | 20160421 | 0 |